NadiaKarenMalikMD

Radiation Oncology • Buffalo, NY

Associate Professor, Radiation Oncology Director of Thoracic and Hepatobiliary/Pancreas Program Roswell Park Comprehensive Cancer Center

Join to view full profile

Dr. Malik is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Malik's full profile

Already have an account?

Office
Elm and Carlton St
Buffalo, NY 14263
Phone+1 716-845-2300

Fax+1 716-845-8254

Summary

Dr. Nadia Malik graduated from Northeast Ohio Medical University and completed her residency in Radiation Oncology in 2012 at Roswell Park Cancer Institute. She is board certified in radiation oncology and has several publications in reputable journals. She recently returns from working as a Consultant Radiation Oncologist at the American Hospital, Dubai, UAE where she helped lead the first SBRT program in the region. She returns to Roswell Park as a Clinical Assistant Professor. She is committed to providing the best oncology care for her patients and to promote awareness in the region.

Education & Training

University at BuffaloResidency, Radiation Oncology, 2008 - 2012
Loyola University Medical CenterInternship, Internal Medicine, 2007 - 2008
Northeast Ohio Medical UniversityClass of 2007
State University of New York at BuffaloB.A., English, Cum Laude, 2002

Certifications & Licensure

NY State Medical License 2012 - 2025
FL State Medical License 2017 - 2019
IN State Medical License 2013 - 2017
IL State Medical License 2007 - 2014
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Walter T. Murphy Teaching Award Roswell Park Cancer Institute, 2015
ABS LDR Prostate Brachytherapy Scholarship Long Island Jewish Medical, 2013
Delegate of the Royal College of Physicians (RCP) Educator Program SUNY Buffalo, 2013

Publications & Presentations

PubMed

Differences between Survival Rates and Patterns of Failure of Patients with Lung Adenocarcinoma and Squamous Cell Carcinoma Who Received Single-Fraction Stereotactic B...
Tyler V Schrand, Austin J Iovoli, Neil D Almeida, Han Yu, Nadia Malik
Cancers. 2024-02-12
Long-Term Survival and Failure Outcomes of Single-Fraction Stereotactic Body Radiation Therapy in Early Stage NSCLC.
Austin J Iovoli, Sharan Prasad, Sung Jun Ma, Fatemeh Fekrmandi, Nadia K Malik
JTO Clinical and Research Reports. 2023-12-01
1 citations
Sinoatrial Node Dose Is Associated With Worse Survival in Patients Undergoing Definitive Stereotactic Body Radiation Therapy for Central Lung Cancers.
Austin J Iovoli, Han Yu, Pragati G Advani, Lauren Turecki, Harish K Malhotra
Practical Radiation Oncology. 2023-10-05

Abstracts/Posters

Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer
G Yang, N Malik, R Chandrasekhar, W Ma, L Flaherty, R Iyer, B Kuvshinoff, J Gibbs, G Wilding, G Warren, K Salerno, Multiple presentations, 1/1/2013
Outcomes in patients 65 years or older treated with trimodality therapy for esophageal carcinoma
N.K. Malik, S. Patil, A. Groman, H. Nava, S. Yendamuri, S. Nurkin, T. Sher, G. Warren, G. Yang, K. May, ASTRO, 1/1/2011
Outcomes and Tolerability of Treatment for Locally Advanced Pancreatic Cancer Patients 65 Years or Older
N.�K.�Malik,�K.�May,�A.�Groman,�S.�Patil,�J.�Gibbs,�B.�Kuvshinoff,�W.�Ma,�R.�Iyer,�G.Warren,�G.Yang, ASTRO, 1/1/2011
A�Comparison�of�VMAT,�IMRT,�and�3DCRT�in�the�Treatment�Planning�of�Patients�with�Distal�Esophageal�Cancer
Patil�S,�Malik�N,�May�K�,�Hackett�R,�Hales,�VanBenthuysen�L,�Schmitt�J,�Groman�A,�Yang�G,�Warren G, ASTRO, 1/1/2011
A Comparison of IMRT and 3DCRT in the Treatment Planning of Patients with Distal esophageal Cancer
S Patil, N Malik, G Yang, K Zeeck, T Papsidero, S Yendamuri, N Khushalani, H Nava, G Warren, K Salerno May, GI ASCO, 1/1/2011
Outcomes of Esophageal Carcinoma Patients Treated with Trimodality Therapy: A Single Institution Experience
N Malik, G Yang, S Patil, K Zeeck, T Papsidero, S Yendamuri, N Khushalani, H Nava, G Warren, K Salerno May, American Radium Society abstract; UB Scholarly Exchange day; UB Surgery research day, 1/1/2011
Join now to see all

Lectures

Establishing local confidence limit and optimization of VMAT patient specific quality assurance
American Hospital, Dubai, UAE - 1/1/2017
Treatment of Locally Advanced Unresectable Pancreatic Cancer: A 10-year experience
1/1/2012
Response based outcomes in esophageal cancer patients treated with primarily non cisplatin and 5-fluorouracil based trimodality therapy
1/1/2011
The impact of smoking history on response and survival outcomes in esophageal cancer patients treated with neoadjuvant concurrent chemoradiotherapy followed by surgery
1/1/2011
Join now to see all